header_image

vTv Therapeutics
2023 Annual Meeting

Investor Materials

Annual Report

Our report on activities & financial performance throughout the year.

View Document

Proxy Statement

Details about our annual meeting & matters to be voted upon.

View Document

Information Statement

View Our Information Statement.

View Document
Request Materials

Request paper copies of the proxy materials online, by email or by phone by dialing 866-648-8133.

OnlineEmail

Vote Now

Your vote is important!
Please vote your proxy online now or by dialing 866-240-5352.

Vote Online

Meeting Details

Date:

June 6, 2023

Time:

9:00 a.m. Eastern Time

Virtual Meeting:

Register

Note: You must register to be eligible to participate in the meeting.

About Us

Who We Are

vTv Therapeutics is a clinical stage biotech company committed to improving the lives of diabetes patients.

Our Science

vTv has a pipeline of drug candidates led by TTP399, a potentially transformative treatment for the reduction of hypoglycemic episodes in type 1 diabetes patients.

Learn More